InsiderClue
Insiders · Profile

Riley Antony A

CHIEF FINANCIAL OFFICER at Forte Biosciences · Chief Financial Officer at Krystal Biotech. Filing since 22 May 2018. CIK 0001339375

FBRX Forte Biosciences, Inc. CHIEF FINANCIAL OFFICER · 5 trades KRYS Krystal Biotech, Inc. Chief Financial Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
FBRX Forte Biosciences, Inc.
30 Dec 2025
CHIEF FINANCIAL OFFICER
Bought
9,680
$254.83K
30.4%
FBRX Forte Biosciences, Inc.
21 Nov 2024
CHIEF FINANCIAL OFFICER
Bought
22,514
$125.00K
273%
FBRX Forte Biosciences, Inc.
7 Sep 2021
Chief Financial Officer
Sold, plan not stated
25,000
$106.11K
69.3%
FBRX Forte Biosciences, Inc.
29 Jun 2020
Chief Financial Officer
Bought
2,000
$28.22K
5.9%
FBRX Forte Biosciences, Inc.
26 Jun 2020
Chief Financial Officer
Bought
4,700
$68.23K
16.0%
KRYS Krystal Biotech, Inc.
22 May 2018
Chief Financial Officer
Bought
2,800
$30.10K
opened
6 decisions on file.